Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study

INTRODUCTION: Research has shown that glycemic control is associated with lower rates of microvascular and long-term cardiovascular complications. In the analyses reported here, we examined treatment failure on oral glucose-lowering agents (GLAs), defined as having sustained hemoglobin A1c (HbA1c) ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Boye, Kristina S., Lage, Maureen J., Kiljański, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099964/
https://www.ncbi.nlm.nih.gov/pubmed/33837921
http://dx.doi.org/10.1007/s13300-021-01051-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099964/
https://www.ncbi.nlm.nih.gov/pubmed/33837921
http://dx.doi.org/10.1007/s13300-021-01051-9

Ejemplares similares